Fudan Zhangjiang Bio-Pharmaceutical Enrolls First Patient for Glioma Drug Trial
Fudan Zhangjiang Bio-Pharmaceutical Enrolls First Patient for Glioma Drug Trial
復旦張江生物製藥開始招募膠質瘤藥物試驗的第一名患者。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊